1 min read|101 words
๐จ Breaking Newsvia BMJ Global Health
Background The 2022 global mpox epidemic declined before modified Vaccinia AnkaraโBavarian Nordic (MVA-BN) vaccines were widely deployed, contributing to the perception that transmission was self-limiting within a small high-risk population. This may have delayed global vaccine allocation and weakened responses to the resurgence that has disproportionately affected Africa since 2024. The reasons for the 2022 decline remain uncertain, and prior studies have reported widely divergent estimates of vaccination impact. We systematically reviewed and meta-analysed the evolving transmissibility of mpox cladesโฆ
This is a developing story.
Source: Dynamics of global mpox epidemics, 1970-2025: a systematic review andโฆ
Was this article helpful?
